| Title: | Accelerated biological aging is associated with faster multimorbidity progression: a UK biobank study |
| Journal: | GeroScience |
| Published: | 7 Apr 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41945275/ |
| DOI: | https://doi.org/10.1007/s11357-026-02213-y |
| Title: | Accelerated biological aging is associated with faster multimorbidity progression: a UK biobank study |
| Journal: | GeroScience |
| Published: | 7 Apr 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41945275/ |
| DOI: | https://doi.org/10.1007/s11357-026-02213-y |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
This study examined the associations of biological age accelerations (BAAs) - KDM-BA acceleration (via Klemera and Doubal's method) and PhenoAge acceleration (epigenetics-based), defined as residuals from regressing each biological age estimate on chronological age (CA) - with multimorbidity progression (measured by the Charlson Comorbidity Index, CCI), compared to CA. Utilizing UK Biobank data (n = 317,835; median follow-up: 13 years), Cox regression models adjusted for sex, ethnicity, lifestyle, and socioeconomic factors showed that each 1-year increase in KDM-BA acceleration raised the risk of CCI progression by 9.9% (HR [95% CI]: 1.099 [1.094-1.104]) and in PhenoAge acceleration by 4.3% (HR [95% CI]: 1.043 [1.041-1.044]). Consistent results were found in subgroup, sensitivity, and restricted cubic spline analyses, with PhenoAge acceleration achieving the highest predictive performance (C-index = 0.6755) compared to KDM-BA acceleration (0.6734) and CA (0.6701). These findings support the use of BAAs as cost-effective tools for assessing the risk of multimorbidity progression.</p>
| Application ID | Title |
|---|---|
| 106707 | Causal effects of environmental, lifestyle, and genetic factors on chronic diseases. |
Enabling scientific discoveries that improve human health